Is it safe?
Can BEAM take a bad year?
Beam Therapeutics Inc. holds $1.05B more cash than debt, and is burning $93M a quarter, about 3.1 years of cover.
$1.05B
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Altman Z-score
- 7.26
Altman Z-score · safe zone, above 3
- Cash runway
- 3.1 years
Cash runway · burning $93M a quarter at the current rate
Details›
- Total debtQ2 2026
- $100M
- Cash and short-term investments
- $1.15B
- Net cash
- $1.05B
- EBITDA, trailing twelve months
- −$356M
- Operating profit, trailing twelve months
- −$378M
- Debt / equity
- 0.09×
- Annualised volatilitytwo years of daily moves
- 74%
- Worst drawdown on file
- −89%
- Below its 52-week high
- −15%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.